BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37773509)

  • 41. [Gastroesophageal Reflux Disease].
    Park CH; Lee SK
    Korean J Gastroenterol; 2019 Feb; 73(2):70-76. PubMed ID: 30845382
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antacid use and subclinical interstitial lung disease: the MESA study.
    Restivo MD; Podolanczuk A; Kawut SM; Raghu G; Leary P; Barr RG; Lederer DJ
    Eur Respir J; 2017 May; 49(5):. PubMed ID: 28526800
    [No Abstract]   [Full Text] [Related]  

  • 43. Treatment of gastro-oesophageal reflux disease in adults.
    Galmiche JP; Letessier E; Scarpignato C
    BMJ; 1998 Jun; 316(7146):1720-3. PubMed ID: 9614026
    [No Abstract]   [Full Text] [Related]  

  • 44. Medical Treatment of Gastroesophageal Reflux Disease.
    Kroch DA; Madanick RD
    World J Surg; 2017 Jul; 41(7):1678-1684. PubMed ID: 28321555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Marked increase in proton pump inhibitors use in Australia.
    Hollingworth S; Duncan EL; Martin JH
    Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):1019-24. PubMed ID: 20623646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Review article: the management of heartburn in pregnancy.
    Richter JE
    Aliment Pharmacol Ther; 2005 Nov; 22(9):749-57. PubMed ID: 16225482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of the primary care provider in the diagnosis and management of heartburn.
    Kushner PR
    Curr Med Res Opin; 2010 Apr; 26(4):759-65. PubMed ID: 20095795
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review article: the management of heartburn during pregnancy and lactation.
    Thélin CS; Richter JE
    Aliment Pharmacol Ther; 2020 Feb; 51(4):421-434. PubMed ID: 31950535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates.
    Malcolm WF; Cotten CM
    Clin Perinatol; 2012 Mar; 39(1):99-109. PubMed ID: 22341540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathophysiology and pharmacological treatment of gastroesophageal reflux disease.
    Storr M; Meining A; Allescher HD
    Dig Dis; 2000; 18(2):93-102. PubMed ID: 11060472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [As-needed treatment with gastric acid inhibitors in gastroesophageal reflux disease].
    Poen AC; Otten MH
    Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1632-6. PubMed ID: 12966628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic sclerosis and reflux.
    Petronovich JJ; Bock JM
    Ear Nose Throat J; 2013; 92(4-5):192-4. PubMed ID: 23599100
    [No Abstract]   [Full Text] [Related]  

  • 53. New algorithm for the treatment of gastro-oesophageal reflux disease.
    Tytgat GN; McColl K; Tack J; Holtmann G; Hunt RH; Malfertheiner P; Hungin AP; Batchelor HK
    Aliment Pharmacol Ther; 2008 Feb; 27(3):249-56. PubMed ID: 17973975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Body mass index and the efficacy of acid-mediating agents for GERD.
    Jacobson BC
    Dig Dis Sci; 2008 Sep; 53(9):2313-7. PubMed ID: 18629639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bone up on proton pump inhibitors and fracture risk.
    Gendreau-Webb R
    Nursing; 2007 Oct; 37(10):60-1. PubMed ID: 17906557
    [No Abstract]   [Full Text] [Related]  

  • 56. Limited efficacy of antigastroesophageal reflux medications in children.
    Berman J
    J Pediatr; 2015 May; 166(5):1321-2. PubMed ID: 25919740
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment of gastroesophageal reflux disease: to step or not to step.
    McGuigan JE
    Am J Gastroenterol; 2001 Jun; 96(6):1679-81. PubMed ID: 11419813
    [No Abstract]   [Full Text] [Related]  

  • 58. A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease.
    Kobeissy AA; Hashash JG; Jamali FR; Skoury AM; Haddad R; El-Samad S; Ladki R; Aswad R; Soweid AM
    World J Gastroenterol; 2012 May; 18(19):2390-5. PubMed ID: 22654431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Over the counter H2 receptor antagonists. Serve only as expensive antacids.
    Douds AC; Maxwell JD
    BMJ; 1994 Oct; 309(6962):1156. PubMed ID: 7987114
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.